Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North-East of Spain, a population-based study

Ophthalmic Epidemiology
Romero-Aroca PedroMéndez-Marin Isabel

Abstract

To determine the prevalence of microangiopathy, and its risk factors in a population-based study of diabetes mellitus patients in the north-eastern area of Spain. A population-based transversal study of 8,187 type 2 (83.37% of the diagnosed patients) and 488 type 1 (85.76% of the diagnosed patients) underwent a detailed medical history that included: diagnoses of diabetic retinopathy, macular edema, microalbuminuria or overt nephropathy. A study of its risk factors, and the relationship between diabetic retinopathy and renal lesion was performed. In type 1 diabetes patients we observed a prevalence of 36.47% of diabetic retinopathy and 5.73% with macular edema; in type 2 diabetes patients the prevalence of diabetic retinopathy was 26.11% and 6.44% with macular edema. Microalbuminuria prevalence was 25.61% in type 1 and 17.78% in type 2 patients, and overt nephropathy prevalence was 8.60% in type 1 and 6.74% in type 2 diabetic patients. The risk factors for diabetic retinopathy were: diabetes duration, high glycosylated level, and arterial hypertension, and insulin treatment in type 2. The Total-cholesterol/High Density-cholesterol (TC/HDL) ratio and triglycerides were significant for diabetic macular edema (DME). Microalbuminur...Continue Reading

References

Jan 1, 1984·Brain and Language·N R Varney
May 1, 1995·Current Opinion in Nephrology and Hypertension·F L Brancati, A M Cusumano
May 23, 1998·Diabetes Research and Clinical Practice·B Lundman, L Engström
Apr 13, 1999·Diabetes Research and Clinical Practice·C CastellL Salleras
May 5, 1999·Diabetic Medicine : a Journal of the British Diabetic Association
Feb 11, 2000·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·M ToellerW A Scherbaum
Jan 6, 2001·The American Journal of Pathology·A M JoussenA P Adamis
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Feb 1, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Antonia M JoussenAnthony P Adamis
Jun 5, 2002·Ophthalmic Epidemiology·Isabel M LópezCarlos J Pastor
Mar 29, 2003·Diabetes Care·Peter HovindHans-Henrik Parving
Sep 18, 2003·Ophthalmology·C P WilkinsonUNKNOWN Global Diabetic Retinopathy Project Group
Aug 17, 2004·The Medical Clinics of North America·Ali JawaVivian A Fonseca
Apr 2, 2005·Archivos de la Sociedad Española de Oftalmología·E Santos BuesoJ Fernández Perianes
Nov 28, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Maria C E RossiSalvatore De Cosmo

❮ Previous
Next ❯

Citations

Aug 24, 2011·World Journal of Diabetes·Pedro Romero-Aroca
Jan 1, 2014·Annals of Medical and Health Sciences Research·R KaroliA Ali
Jun 3, 2014·BMC Endocrine Disorders·Steven JamesKatharine Steinbeck
Jan 22, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·L M RutaJ E Shaw
Oct 17, 2012·Diabetes Research and Clinical Practice·A K MottlA V Kshirsagar
May 1, 2012·Survey of Ophthalmology·Sobha SivaprasadJennifer Evans
Oct 25, 2011·Diabetes Research and Clinical Practice·Yi-Ming MuKevin E K Tan
Aug 2, 2011·Diabetes Research and Clinical Practice·Pedro Romero-ArocaAngel Bautista-Perez
Jul 31, 2013·The Journal of Clinical Hypertension·Tomislav BulumLea Duvnjak
Mar 19, 2014·Journal of Diabetes·Charumathi SabanayagamTien Yin Wong
Nov 26, 2015·Eye and Vision·Ryan LeeCharumathi Sabanayagam
Aug 16, 2014·Journal of Diabetes and Its Complications·Amy K MottlJohn Buse
Feb 18, 2016·PloS One·Antonio Rodríguez-PoncelasGabriel Coll-de Tuero
Jan 22, 2017·The British Journal of Ophthalmology·Srividya NeriyanuriRajiv Raman
Jun 26, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Amna ParveenSun Yeou Kim
Mar 23, 2011·Current Opinion in Nephrology and Hypertension·Elisabeth J J ValkIngeborg M Bajema
Apr 10, 2020·Medicina·Wojciech MatuszewskiElżbieta Bandurska-Stankiewicz
Jul 21, 2020·Expert Review of Pharmacoeconomics & Outcomes Research·Aus AlzaidPetar Atanasov
Jul 28, 2020·The British Journal of Nutrition·Parivash GhorbaninejadSakineh Shab-Bidar
Aug 15, 2020·Oman Journal of Ophthalmology·Puspalata AgroiyaNoor Bader Al Busaidi
Sep 9, 2020·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Ross T AitchisonUma Shahani
Feb 16, 2019·Current Diabetes Reviews·Abdul Hamid Al Ghamdi
Jun 27, 2019·Central European Journal of Public Health·Antonela Gverović AntunicaMaja Šikić
Jan 12, 2021·Saudi Journal of Biological Sciences·Jamila HammoudiAbderrahim Ziyyat
Nov 7, 2020·Archivos de la Sociedad Española de Oftalmología·Cristina Peris-MartínezAmber A van der Heijden
Dec 20, 2017·Value in Health Regional Issues·Pieralessandro LasalviaDiego Rosselli

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.